Pulmonary hypertension in HIV-infected drug-addicts. A 10 case report;Hypertension arterielle pulmonaire chez le toxicomane VIH+. A propos de 10 cas

Revue des Maladies Respiratoires

Volumn 15, Issue 1, 1998, Pages 97-102

  Petureau F ^a   Escamilla, R ^a   Hermant, C ^a   Mourlanette, P ^a   Berjaud, J ^a   Krempf, M ^a  

^a CHU PURPAN   (France)

Author keywords

Drug addiction; HIV; Pulmonary hypertension

Indexed keywords

AMPHETAMINE; ANTICOAGULANT AGENT; COCAINE; OPIATE; CARDIOLIPIN ANTIBODY; NARCOTIC AGENT; RESPIRATORY TRACT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; LONG TERM CARE; MALE; PORTAL HYPERTENSION; PROGNOSIS; PULMONARY HYPERTENSION; SUBSTANCE ABUSE; BLOOD; CAUSE OF DEATH; COCAINE DEPENDENCE; DISEASE COURSE; DRUG ABUSE; DRUG CONTRAINDICATION; MIDDLE AGED; PRESCRIPTION; PULMONARY ARTERY; SERODIAGNOSIS; SURVIVAL RATE; WITHDRAWAL SYNDROME;

ADULT; AMPHETAMINE-RELATED DISORDERS; ANTIBODIES, ANTICARDIOLIPIN; ANTICOAGULANTS; CAUSE OF DEATH; COCAINE-RELATED DISORDERS; DISEASE PROGRESSION; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NARCOTICS; PRESCRIPTIONS, DRUG; PROGNOSIS; PULMONARY ARTERY; RESPIRATORY SYSTEM AGENTS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE WITHDRAWAL SYNDROME; SURVIVAL RATE;

EID: 0031993678     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. CORDIER JF : Etiologies et physiopathologie des hypertensions artérielles pulmonaires. Rev Prat 1991;41:1534-40.
2. RUBIN LJ : Primary pulmonary hypertension. Chest 1993;104:236-50.
3. GOLDSMITH GH, BAILY RG, BRETTLER DB, DAVIDSON WR et al. : Primary pulmonary hypertension in patients with classic hemophilia. Ann Inter Med 1988;108:797-9.
4. COPLAN NL, SHIMONY RY, IOACHIM HL, WILENTZ JR et al. : Primary pulmonary hypertension associated with human immunodeficiency viral infection. Am J Med 1990;89:96-9.
5. POLOS PG, WOLFE D, HARLEY RA, STRANGE C, SAHN SA : Pulmonary hypertension and human immunodeficiency virus infection. Two reports and a review of the literature. Chest 1992;101:474-8.
6. PIETTE AM, LEGOUX B, GEPNER P et al. : Hypertension artérielle pulmonaire primitive associée à l'infection par le VIH. Presse Med 1992;21:616-8.
7. METTE SA, PALEVSKY HI, PIETRA GG et al. : Ṗrimary pulmonary hypertension in association with HIV infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis 1992;145:1196-200.
8. SPEICH R, JENNI R, OPRAVIL M, PFAB M, RUSSI EW : Primary pulmonary hypertension in HIV infection. Chest 1991;100:1268-71.
9. PETITPRETZ P, BRENOT F, AZARIAN R et al. Pulmonary hypertension in patients with HIV infection. Circulation 1994;89:2722-7.
10. ARNETT EN, BATTLE WE, Russo JV, ROBERTS WC : Intravenous injection of talc-containing drugs intented for oral use. Am J Med 1976;60:711-8.
11. MURRAY RJ, SMIALEK JE, GOLLE M, ALBIN RJ : Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest 1989;96:1050-3.
12. WEITZENBLUM E, KESSLER R, CHAOUAT A : Hypertension artérielle pulmonaire d'origine iatrogène. Rev Mal Respir 1996;13:133-9.
13. MC DONNEL PF, TOYE PA, HUTCHINS GM : Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis 1983;127:437-41.
14. OPRAVIL M, PECHERE M, SPEICH R et al. : HIV-associated primary pulmonary hypertension. A case control study. Am J Respir Crit Care Med 1997;155:990-5.
15. Bulletin Epidémiologique Hebdomadaire : 1996, no10; 45-52.
16. HERON E, LAABAN JP, CAPRON F et al. : Thrombotic primary pulmonary hypertension in an HIV+ patient. Eur Heart J 1994;15:394-6.
17. RUCHELLI ED, NOJADERA G, RUTSTEIN RM et al. : Pulmonary veno-occlusive disease. Another vascular disorder associated with HIV infection? Arch Pathol Lab Med 1994;118:664-6.
18. ESCAMILLA R, HERMANT C, J BERJAUD J et al. : Pulmonary veno-occlusive disease in a HIV-infected intravenous drug abuser. Eur Respir J 1995;8:1982-4.
19. GILLESPIE MN, HARTSFIELD CL, O'CONNOR W, COHEN DA : Pulmonary hypertension in a murine model of the acquired immunodeficiency syndrome. Am J Respir Crit Care Med 1994;150:194-9.
20. HUMBERT M, MONTI G, PETITPRETZ P et al. : Pulmonary hypertension in HIV infected patient is associated with an increased intrapulmonary PDGF production. Am J Respir Crit Care Med 1994;149:A824.
21. KITABATAKE A, INOUE M, ASAO M et al. : Noninvasive evaluation of pulmonary hypertension by a pulsed doppler technique. Circulation 1983;68:302-9.
22. SITBON O, BRENOT F, DENJEAN A et al. : Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. Am J Respir Crit Care Med 1995;151:384-9.
23. GALIE N, USSIA G, PASSARELLI P et al. : Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol 1995;75:55A-62A.
24. LAFEVILLADE A, ALESSI MC, MARTIN-POIZOT I et al. : Protein S deficiency and HIV infection. N Engl J Med 1991;324:1220.
25. BECKER DM, SAUNDERS TJ, WISPELWEY B et al. : Case report: Venous thromboembolism in AIDS. Am J Med Sci 1992;303:395-7.
26. RUBIN LJ, MENDOZA J, HOOD M et al. : Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of randomized trial. Ann Intern Med 1990;112:485-91.
27. CREMONA G, HIGENBOTTAM T : Role of prostacyclin in the treatment of primary pulmonary hypertension. Am J Cardiol 1995;75:67A-71A.
28. GILROY RJ, TEAGUE MW, LOYD JE : Pulmonary veno-occlusive disease. Fatal progression of pulmonary hypertension despite steroid-induced remission of interstitial pneumonitis. Am Rev Respir Dis 1991;143:1130-3.